Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Karolinska Univ Hospital, Stockholm, Sweden

2 abstracts

Abstract
ACHIEVING LONG-TERM COMPREHENSIVE DISEASE CONTROL WITH ADALIMUMAB AND METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS IN THE OPTIMA STUDY
Org: Univ of Leeds, Leeds, United Kingdom, Medical Univ of Vienna & Hietzing Hospital, Vienna, Austria, U of Texas Southwestern Med Center, Dallas, United States, Karolinska Univ Hospital, Stockholm, Sweden, Abbott, Abbott Park, United States,
Abstract
BIOLOGIC FREE DISEASE CONTROL (BFDC) IN EARLY RA: PREDICTORS OF SUCCESSFUL WITHDRAWAL OF ADALIMUMAB (ADA) AFTER ACHIEVING STABLE LOW DISEASE ACTIVITY WITH ADA PLUS METHOTREXATE (MTX) – DATA FROM THE OPTIMA STUDY
Org: Medical Univ of Vienna, Vienna, Austria, Leeds Teaching Hospital, Leeds, United Kingdom, U of Texas Southwestern Med Center, Dallas, United States, Karolinska Univ Hospital, Stockholm, Sweden, Abbott, Abbott Park, United States,